Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sorrento Therapeutics Inc
SRNE
Healthcare
Biotechnology
Sorrento Therapeutics, Inc. is a clinical and commercial stage biopharmaceutical company. The Company is engaged in developing new therapies to treat cancer, pain (non-opioid treatments), autoimmune diseases and COVID-19. The Company’s segments include Sorrento Therapeutics and Scilex. The Sorrento Therapeutics segment is organized around its Immune-Oncology therapeutic area, leveraging its G...
-MAB antibody library and targeted delivery modalities to generate the next-generation of cancer therapeutics. The Scilex segment is organized around its non-opioid pain management operations and clinical pipeline. The Company’s immuno-oncology platforms, including its fully human antibodies (G-MAB library), ACEA small molecule library, immuno-cellular therapies (DAR-T), antibody-drug conjugates (ADCs) and oncolytic virus (Seprehvec). The Company is also developing potential antiviral therapies against COVID-19, including FUJOVEE (Abivertinib) and its rapid diagnostic test, including COVIMARK.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:SRNE)
New Post
View:
Posts & Comments
Threaded Posts
(9)
•••
MikeTester
X
View Profile
View Bullboard History
Post by
MikeTester
on Aug 03, 2024 1:23pm
Sorrento Therapeutics, Inc. (SRNE): A Biopharmaceutical Powe
https://beyondspx.com/2024/08/03/sorrento-therapeutics-inc-srne-a-biopharmaceutical-powerhouse-navigating-turbulent-times/
(40)
•••
TMAZZ21
X
View Profile
View Bullboard History
Post by
TMAZZ21
on Apr 13, 2024 3:28pm
SCLX DIVIDENDS
Any other Canadians on here? Writing up a letter to the CRA - Canada Revenue Agency when sending in my taxes. Regarding the distribution and valuation of the SCLX shares.
...more
Level Up Your Trading with BMO InvestorLine’s Enhanced Features
posted Nov 23, 2024 9:00am by
Bank of Montreal
-
|
Features like Multi-Leg Orders, Options Screener, and Strategy Builder will be particularly exciting for traders. They have been designed to be intuitive and user-friendly, regardless of your experience level. Whether you’re a seasoned pro or just starting out, you’ll find these tools easy to navigate and adapt to your investing style. ...read more
(394)
•••
Tarbaby
X
View Profile
View Bullboard History
Post by
Tarbaby
on Dec 23, 2022 9:48am
Stock price drop
What is happening. Why such a drastic drop in price.
(4)
•••
zeropointenergy
X
View Profile
View Bullboard History
Post by
zeropointenergy
on Oct 06, 2021 7:09am
ONE DRUG PILL WIPES OUT COVID 19!
India's Ivermectin Blackout - Part V: The Secret Revealed ... Sep 27, 2021 · By September 12, 2021, Livemint reported that 34 districts were declared COVID-free
...more
(4)
•••
zeropointenergy
X
View Profile
View Bullboard History
Comment by
zeropointenergy
on Oct 06, 2021 7:07am
RE:Commercialization of COVI-STIX
India's Ivermectin Blackout - Part V: The Secret Revealed ... Sep 27, 2021 · By September 12, 2021, Livemint reported that 34 districts were declared COVID-free
...more
(20)
•••
TheeRook
X
View Profile
View Bullboard History
Post by
TheeRook
on Jul 20, 2021 10:22pm
Commercialization of COVI-STIX
SAN DIEGO, July 20, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that it has formed a subsidiary company based in Mexico City, Sorrento
...more
(20)
•••
TheeRook
X
View Profile
View Bullboard History
Post by
TheeRook
on Jun 25, 2021 5:29pm
EUA Approval and Import License From Mexico Authority COFEPR
Sorrento Receives EUA Approval and Import License From Mexico Authority COFEPRIS For COVI-STIX ™ (COVID-19 Virus Rapid Antigen Detection Test) and Plans Product Launch With Initial Shipments in July
...more
(20)
•••
TheeRook
X
View Profile
View Bullboard History
Post by
TheeRook
on Jun 23, 2021 3:29am
No. 3 (NAMRU-3) For Pandemic Preparedness Combating COVID-19
Interesting Sorrento Enters Into Multi-Year Cooperative Research and Development Agreement With the U.S. Naval Medical Research Unit – No. 3 (NAMRU-3) For Pandemic Preparedness Combating COVID-19
...more
(20)
•••
TheeRook
X
View Profile
View Bullboard History
Post by
TheeRook
on Jun 02, 2021 3:03pm
COVI-STIX added to the official government list in Mexico
Mexican Comisin Federal para la Proteccin contra Riesgos Sanitarios (COFEPRIS), the health regulatory authority for Mexico, has listed COVI-STIX on its official government website list of rapid
...more
(20)
•••
TheeRook
X
View Profile
View Bullboard History
Comment by
TheeRook
on Jan 21, 2021 4:46am
RE:RE:Latest discussions
Sorrento Therapeutics, Inc. (SRNE) Transcript on SA Transcripts https://seekingalpha.com/article/4400090-sorrento-therapeutics-inc-srne-ceo-henry-ji-presents-b-riley-virtual
...more
(20)
•••
TheeRook
X
View Profile
View Bullboard History
Comment by
TheeRook
on Jan 21, 2021 4:13am
RE:Latest discussions
From Don I heard the entire presentation...it is worth a listen. I know many are interested in Sorrento's stem cell treatment for severely ill ICU patients. Dr. Ji said the third patient has just
...more
(20)
•••
TheeRook
X
View Profile
View Bullboard History
Post by
TheeRook
on Jan 21, 2021 3:57am
Latest discussions
From JD Have a listen to today's discussion with Dr. Henry Ji. My highlights from in his words. Slightly Paraphrase. • Abivertinib now in 40 patients for Covid19. "So Happy with the things
...more
(20)
•••
TheeRook
X
View Profile
View Bullboard History
Post by
TheeRook
on Dec 23, 2020 2:36am
COVID-STIX
sensitivity of 98%, a specificity of 100%, and an LOD of 6.25 TCID50/swab Sorrento Announces It Has Submitted An Emergency Use Authorization (EUA) Application to the FDA for COVI-STIX™ Rapid Test
...more
(20)
•••
TheeRook
X
View Profile
View Bullboard History
Post by
TheeRook
on Nov 27, 2020 1:00pm
DARPA
Another to add DARPA and JPEO Award Contract to SmartPharm, a Subsidiary of Sorrento, for Development of Rapid Countermeasure Against COVID-19 Using Gene-Encoded Neutralizing Antibodies
...more
(20)
•••
TheeRook
X
View Profile
View Bullboard History
Post by
TheeRook
on Aug 08, 2020 4:33am
new rapid diagnostic test that Sorrento recently licensed fr
What happened Shares of Sorrento Therapeutics (NASDAQ:SRNE) rocketed 31% higher on Tuesday, following bullish comments from a respected analyst. So what H.C. Wainwright analyst
...more
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >